Integrated Diagnostics (LON:IDHC) Trading Up 0.3% - Should You Buy?

Integrated Diagnostics Holdings plc (LON:IDHC - Get Free Report)'s share price was up 0.3% on Thursday . The company traded as high as GBX 0.34 ($0.00) and last traded at GBX 0.34 ($0.00). Approximately 45,384 shares were traded during mid-day trading, a decline of 85% from the average daily volume of 309,546 shares. The stock had previously closed at GBX 0.34 ($0.00).

Integrated Diagnostics Stock Up 1.7%

The stock has a market cap of £10.30 billion, a price-to-earnings ratio of 13.01, a PEG ratio of 7.65 and a beta of 0.59. The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 45.72. The stock has a fifty day moving average of GBX 0.35 and a two-hundred day moving average of GBX 0.39.

Integrated Diagnostics Company Profile

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and radiology tests to patients in Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia. The Group's core brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Biolab KSA (Saudi Arabia).